Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP3772 Phase 1/2 in Adults and Elderly
NCT03803202Phase 2Completed
- Sponsor
- GSK
- Start
- Jan 2019
- Primary completion
- Sep 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of AFX3772 in pneumococcal disease, bacterial pneumonia, sponsored by GSK. Started Jan 2019; status: completed.
02
Drugs
AFX3772
03
Conditions
pneumococcal diseasebacterial pneumonia
Beyond the preview
Go deeper on NCT03803202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03803202.